We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone Tumors

News   Jun 13, 2018 | Original story from the Sanger Institute

 
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone Tumors

Osteosarcoma cell with DNA in blue, energy factories (mitochondria) in yellow and actin filaments, part of the cellular skeleton, in purple. Credit: Dylan Burnette and Jennifer Lippincott-Schwartz, NIH

 
 
 

RELATED ARTICLES

Brain Cancer Potentially Resists Immunotherapies by Trapping T Cells in Bone Marrow

News

Certain brain cancers are associated with low numbers of immune system T-cells circulating in the peripheral blood. Low T-cell numbers can be a side-effect of cancer treatment. But it now appears that there is more to the story of these missing T-cells.

READ MORE

Retinoic Acid may Improve Immune Response Against Melanoma

News

Scientists have found a promising strategy to remove one of melanoma’s most powerful defenses, leading to more immune system activity directed at melanoma.

READ MORE

PCR Assay Helps ID Sarcoma Mutations

News

Sarcomas are rare tumors that are often misdiagnosed. A report in the Journal of Molecular Diagnostics describes a new assay, anchored multiplex PCR (AMP)-based targeted next-generation-sequencing (NGS), that is better able to identify genetic diagnostic markers of the cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE